Cutting edge industry-driven research projects

The CBI partners with leading Australian stakeholders in the biologics industry and aims to blend research excellence with industry partner experience and know-how.

The ARC Training Centre for Biopharmaceutical Innovation is a multi‑million dollar Australian Government initiative which aims to transform Australia’s growing biopharmaceutical industry


of new biopharmaceuticals and diagnostic agents

Discovery of new biopharmaceuticals and mAbbased reagents utilising innovative methodologies in therapeutic and diagnostic mAb discovery, as well as the development of platform technologies for mAb delivery to intracellular targets.


of mammalian cells as factories for protein

We are working on understanding cellular bottlenecks for production of therapeutic proteins and bypass those bottlenecks by modifying relevant cellular pathways, and engineering the therapeutic proteins for improved expression.

Advanced manufacturing

of biopharmaceuticals

Large-scale cell culture and downstream processing represent the greatest driver of cost of goods for biopharmaceuticals. We are working on process improvements to provide gains in product quality, yield and characterisation.


Major Research Procurement

The Centre for Biopharmaceutical Innovation is ready to intensify downstream bioprocess with the latest AKTA periodic counter current chromatography system-first in an Australian academic institution. We would like to recognize the support of the University of Queensland’s Major Equipment and Infrastructure grant in this procurement. We would also like to thank all UQ schools, institutes and service facilities for their support in […]